These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15850612)

  • 21. A high titer of acquired factor V inhibitor in a hemodialysis patient who developed arterial thrombosis.
    Ogawa H; Souri M; Kanouchi K; Osaki T; Ohkubo R; Kawanishi T; Wakai S; Morikane K; Ichinose A
    Int J Hematol; 2019 Feb; 109(2):214-220. PubMed ID: 30446942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acquired coagulation abnormality due to factor V inhibitor].
    Iino N; Maruyama H; Gejyo F
    Nihon Naika Gakkai Zasshi; 2002 Nov; 91(11):3295-7. PubMed ID: 12652782
    [No Abstract]   [Full Text] [Related]  

  • 23. Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two cases.
    Berezné A; Stieltjes N; Le-Guern V; Teixeira L; Billy C; Roussel-Robert V; Flaujac C; Horellou MH; Guillevin L; Mouthon L
    Transfus Med; 2006 Jun; 16(3):209-12. PubMed ID: 16764602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquired factor V deficiency and mini literature review.
    Kunimoto H; Miyakawa Y; Okamoto S
    Haemophilia; 2012 May; 18(3):e86-7. PubMed ID: 21910794
    [No Abstract]   [Full Text] [Related]  

  • 25. Acquired factor V inhibitor in the setting of coronavirus disease 2019 infection.
    Bennett J; Cunningham MT; Howard C; Hoffmann M; Plapp FV
    Blood Coagul Fibrinolysis; 2021 Jun; 32(4):294-297. PubMed ID: 33443928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of an asymptomatic idiopathic inhibitor to coagulation factor V.
    Lucia JF; Aguilar C
    Haemophilia; 2005 Mar; 11(2):178-80. PubMed ID: 15810922
    [No Abstract]   [Full Text] [Related]  

  • 27. Platelet factor V supports hemostasis in a patient with an acquired factor V inhibitor, as shown by prothrombinase and tenase assays.
    Perdekamp MT; Rubenstein DA; Jesty J; Hultin MB
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):593-7. PubMed ID: 16988558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectrum of bleeding in acquired factor V inhibitor: a summary of 33 cases.
    Wiwanitkit V
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):485-8. PubMed ID: 17000894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient Factor V deficiency associated with Factor V-immunoglobulin complexes but without evidence of a classical inhibitor.
    Cortier D; Van Dreden P; Adam M; Bironien R; François D; Vasse M
    Thromb Res; 2016 Nov; 147():10-12. PubMed ID: 27664390
    [No Abstract]   [Full Text] [Related]  

  • 30. Deep venous thrombosis associated with acquired angioedema type II in a patient heterozygous for the mutation of factor V Leiden: effective treatment and follow-up for four years.
    Széplaki G; Varga L; Osváth L; Karádi I; Füst G; Farkas H
    Thromb Haemost; 2006 May; 95(5):898-9. PubMed ID: 16676085
    [No Abstract]   [Full Text] [Related]  

  • 31. Acquired factor V inhibitor in a patient with gingival squamous cell cancer and tuberculosis.
    Chenthilmurugan R; Kodali S; Chenthilmurugan H; Steier W; Schwartz J; Kalavar M
    Clin Adv Hematol Oncol; 2008 Dec; 6(12):921-7. PubMed ID: 19209142
    [No Abstract]   [Full Text] [Related]  

  • 32. Acquired factor V inhibitor in a patient with acquired human immunodeficiency syndrome.
    Brickner LA; Scannell KA; Sahud MA
    Am J Hematol; 1996 Aug; 52(4):332-3. PubMed ID: 8701963
    [No Abstract]   [Full Text] [Related]  

  • 33. Acquired factor VIII inhibitor in a patient with dermatomyositis--a case study.
    Ayoola A; Mohsini W; Aung S
    Acta Haematol; 2008; 119(1):8-11. PubMed ID: 18176073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombin generation assay in a patient with acquired factor V inhibitor.
    Kindler S; Siegemund T; Führer D; Petros S
    J Thromb Haemost; 2008 Nov; 6(11):1985-7. PubMed ID: 18783483
    [No Abstract]   [Full Text] [Related]  

  • 35. Association of corticosteroids and factor V, prothrombin, and MTHFR gene mutations with avascular osteonecrosis in renal allograft recipients.
    Celik A; Tekis D; Saglam F; Tunali S; Kabakci N; Ozaksoy D; Manisali M; Ozcan MA; Meral M; Gülay H; Camsari T
    Transplant Proc; 2006 Mar; 38(2):512-6. PubMed ID: 16549163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquired Coagulation Factor V Inhibitor That Was Successfully Treated with Oral Corticosteroid Therapy.
    Yokota Y; Inatomi O; Nakagawa M; Kakuda K; Hiroe K; Sakai S; Osaki R; Iwasa M; Kawahara M; Kito K; Andoh A; Bamba H
    Intern Med; 2021 Aug; 60(16):2663-2666. PubMed ID: 34121013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired factor V inhibitor in a critically ill patient.
    Morris CJ; Curry N
    Anaesthesia; 2009 Sep; 64(9):1014-7. PubMed ID: 19686488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late and fatal deterioration of an intracerebral hemorrhage attributable to the onset of a high titer of acquired factor V inhibitor.
    Denier C; Bouteredjiret T; Dreyfus M; Lacroix C; Adams D
    Eur Neurol; 2008; 60(4):206-7. PubMed ID: 18667829
    [No Abstract]   [Full Text] [Related]  

  • 39. Acquired factor V deficiency in a patient without evidence of a classical inhibitor.
    Sosa IR; Ellery P; Mast A; Neff AT; Gailani D
    Haemophilia; 2014 Jan; 20(1):e81-3. PubMed ID: 24118596
    [No Abstract]   [Full Text] [Related]  

  • 40. Acquired prothrombin deficiency in a patient with follicular lymphoma.
    Alamelu J; McCormick A; Moore GW; Madan B
    Haemophilia; 2008 May; 14(3):634-6. PubMed ID: 18355267
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.